Lung Injury Protection by Coagulation Blockade

通过凝血阻断保护肺损伤

基本信息

  • 批准号:
    7455948
  • 负责人:
  • 金额:
    $ 36.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-15 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

This is an amended application designed to investigate the role of the lung's coagulation system in acute lung injury (All). Initiation of coagulation by tissue factor (TF) and persistence of the pro-coagulant state are important in the pathogenesis of acute respiratory distress syndrome (ARDS), especially in sepsis. TF and other coagulation proteins communicate with inflammatory elements that enhance the lung's injury response. In addition, fibrinolysis is inhibited by activation of plasminogen activator inhibitors (PAI-1 and -2) and antiplasmins, which promotes fibrin accumulation and contributes to capillary obliteration, hyaline membrane formation, gas exchange impairment, and lung fibrosis. We show in animals that TF blockade abrogates inflammation in lung injury by lipopolysaccharide (LPS) and lung injury in Gram-negative sepsis. Although coagulation is integrally involved in the pathogenesis of ARDS, it is not clear how the different components of the coagulation cascade interact with inflammatory and fibrinolytic pathways to promote or resolve acute lung injury. To address this issue, we will test the hypothesis: blockade of coagulation initiation is an optimal strategy for lung protection by preventing excessive inflammatory mediator release and cell influx that degrades structure, function, and delays resolution of ALI. We further propose that coagulation factors other than TF, especially thrombin and fibrin, regulate specific aspects of lung inflammation and its resolution in sepsis through independent and coordinate cytokine-signaling events. Three aims are proposed: Aim 1. Determine how TF interacts with specific cytokine/chemokine production that influences leukocyte recruitment and resolution of inflammation in acute lung injury. Aim 2. Determine how thrombin receptor-1 (PAR-1) interacts with specific cytokine/chemokine production that influences leukocyte recruitment and resolution of inflammation in acute lung injury. Aim 3. Determine how plasminogen activator-1 (PAI-1) interacts with specific cytokine-chemokine production that influences leukocyte recruitment and resolution of inflammation in acute lung injury. The implications of improved mechanistic insight into the role of coagulation proteins in acute lung injury are to provide new opportunities to prevent abnormal inflammation and disordered repair through interventions directed at these activities. A successfully optimized strategy could greatly attenuate persistence of pulmonary inflammation and facilitate the resolution of human ARDS.
这是一个修改后的应用程序,旨在研究肺凝血系统在急性肺损伤(All)中的作用。组织因子(TF)启动凝血和促凝状态的持续在急性呼吸窘迫综合征(ARDS)的发病机制中很重要,特别是在败血症中。TF和其他凝血蛋白与炎症因子交流,增强肺损伤反应。此外,纤溶酶原激活剂抑制剂(PAI-1和-2)和抗纤溶酶的激活可抑制纤维蛋白溶解,从而促进纤维蛋白积累,导致毛细血管闭塞、透明膜形成、气体交换障碍和肺纤维化。我们在动物实验中发现,TF阻断可消除脂多糖(LPS)引起的肺损伤和革兰氏阴性脓毒症引起的肺损伤。虽然凝血在ARDS的发病机制中起着重要作用,但凝血级联的不同组分如何与炎症和纤溶途径相互作用以促进或缓解急性肺损伤尚不清楚。为了解决这一问题,我们将验证以下假设:阻断凝血起始是一种最佳的肺保护策略,可以防止过度的炎症介质释放和细胞内流,从而降低ALI的结构、功能和延迟解决。我们进一步提出,除TF以外的凝血因子,特别是凝血酶和纤维蛋白,通过独立和协调的细胞因子信号传导事件,调节败血症中肺部炎症及其消退的特定方面。提出了三个目标:目标1。确定TF如何与影响急性肺损伤中白细胞募集和炎症消退的特定细胞因子/趋化因子产生相互作用。目标2。确定凝血酶受体-1 (PAR-1)如何与影响急性肺损伤中白细胞募集和炎症消退的特定细胞因子/趋化因子产生相互作用。目标3。确定纤溶酶原激活物-1 (PAI-1)如何与影响急性肺损伤中白细胞募集和炎症消退的特定细胞因子-趋化因子产生相互作用。对凝血蛋白在急性肺损伤中的作用机制的深入了解,为通过干预这些活动来预防异常炎症和修复紊乱提供了新的机会。一个成功的优化策略可以大大减轻肺部炎症的持久性,促进人类ARDS的解决。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CLAUDE A PIANTADOSI其他文献

CLAUDE A PIANTADOSI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CLAUDE A PIANTADOSI', 18)}}的其他基金

Respiration in Sepsis
脓毒症时的呼吸
  • 批准号:
    8436690
  • 财政年份:
    2013
  • 资助金额:
    $ 36.98万
  • 项目类别:
Respiration in Sepsis
脓毒症时的呼吸
  • 批准号:
    8666533
  • 财政年份:
    2013
  • 资助金额:
    $ 36.98万
  • 项目类别:
Respiration in Sepsis
脓毒症时的呼吸
  • 批准号:
    8971980
  • 财政年份:
    2013
  • 资助金额:
    $ 36.98万
  • 项目类别:
Redox Regulation of Lung Mitochondrial Biogenesis in Sepsis/Pneumonia
脓毒症/肺炎中肺线粒体生物发生的氧化还原调节
  • 批准号:
    8370970
  • 财政年份:
    2012
  • 资助金额:
    $ 36.98万
  • 项目类别:
Redox Regulation of Lung Mitochondrial Biogenesis in Sepsis/Pneumonia
脓毒症/肺炎中肺线粒体生物发生的氧化还原调节
  • 批准号:
    8462898
  • 财政年份:
    2012
  • 资助金额:
    $ 36.98万
  • 项目类别:
Nitric oxide and mitochondrial biogenesis in sepsis
脓毒症中的一氧化氮和线粒体生物发生
  • 批准号:
    8534342
  • 财政年份:
    2012
  • 资助金额:
    $ 36.98万
  • 项目类别:
Redox Regulation of Lung Mitochondrial Biogenesis in Sepsis/Pneumonia
脓毒症/肺炎中肺线粒体生物发生的氧化还原调节
  • 批准号:
    8675191
  • 财政年份:
    2012
  • 资助金额:
    $ 36.98万
  • 项目类别:
Carbon Monoxide and Mitochondrial Quality Control in Sepsis-induced Lung Injury
脓毒症引起的肺损伤中的一氧化碳和线粒体质量控制
  • 批准号:
    8225578
  • 财政年份:
    2011
  • 资助金额:
    $ 36.98万
  • 项目类别:
Mitochondrial biogenesis in sepsis-induced organ dysfunction
脓毒症引起的器官功能障碍中的线粒体生物发生
  • 批准号:
    8217199
  • 财政年份:
    2009
  • 资助金额:
    $ 36.98万
  • 项目类别:
Mitochondrial biogenesis in sepsis-induced organ dysfunction
脓毒症引起的器官功能障碍中的线粒体生物发生
  • 批准号:
    8021807
  • 财政年份:
    2009
  • 资助金额:
    $ 36.98万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.98万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.98万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.98万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.98万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.98万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.98万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.98万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.98万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.98万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.98万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了